Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |